Bacil Pharma Ltd
Bacil Pharma Ltd (BACPHAR) last traded at ₹11.3, a market capitalisation of ₹16.2 crore, on a P/E of 24.9. Over the past 52 weeks the stock has ranged between ₹11 and ₹61.8. Bacil Pharma Ltd last reported results for the quarter ended Jun 2026, with sales of ₹0 crore and net profit of ₹-0.02 crore. Bacil Pharma Ltd’s board meets on 25 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.
Bacil Pharma Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Bacil Pharma Ltd quarterly results
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.07 | 0.06 | 0.07 | 0.11 | 0.03 | 0.02 | 0.07 | 0.02 |
| Operating profit | -0.07 | -0.06 | -0.07 | -0.11 | -0.03 | -0.02 | -0.07 | -0.02 |
| OPM % | — | — | — | — | — | — | — | — |
| Other income | 0.56 | 0 | 0.09 | 1 | 0.05 | 0.06 | 0.11 | 0.09 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.49 | -0.06 | 0.02 | 0.89 | 0.02 | 0.04 | 0.04 | 0.07 |
| Tax % | 0.00% | 0.00% | 0.00% | 24.72% | 0.00% | 0.00% | -1,450.00% | 114.29% |
| Net profit | 0.48 | -0.06 | 0.02 | 0.67 | 0.01 | 0.04 | 0.62 | -0.02 |
| EPS (₹) | 0.81 | -0.10 | 0.01 | 0.47 | 0.01 | 0.03 | 0.43 | -0.01 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Bacil Pharma Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating profit | -0.16 | -0.16 | -0.17 | -0.19 | -0.25 | -0.25 | -0.14 |
| OPM % | — | — | — | — | — | — | — |
| Net profit | -0.24 | -3.86 | -0.1 | -0.06 | 0.4 | 1.56 | 0.65 |
| EPS (₹) | -0.41 | -6.55 | -0.17 | -0.10 | 0.28 | 1.09 | 0.46 |
TTM is the trailing twelve months to the most recent quarter.
Bacil Pharma Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- 38%
- 5 Years
- 77%
- 3 Years
- 131%
- TTM
- -41%
- 10 Years
- 8%
- 5 Years
- 12%
- 3 Years
- 13%
- 1 Year
- -68%
- 10 Years
- 0%
- 5 Years
- 2%
- 3 Years
- 3%
- Last Year
- 6%
Bacil Pharma Ltd shareholding pattern
Promoters held 0.00% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 20.71% | 10.60% | 0.20% | 0.20% | 0.08% | 0.08% | 0.00% | 0.00% |
| Public | 79.30% | 89.39% | 99.80% | 99.80% | 99.92% | 99.92% | 100.00% | 100.00% |
| No. of shareholders | 6,902 | 7,461 | 7,638 | 7,532 | 7,431 | 7,431 | 7,226 | 7,326 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When does Bacil Pharma Ltd’s board next meet?
Bacil Pharma Ltd’s board meets on 25 Aug 2026.
- Board meetingDiscussion on Appointment of Directors
See the full results calendar for every Indian company reporting in the next 30 days.
Bacil Pharma Ltd corporate filings
- Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 ,inter alia, to consider and approve Board meeting to be held on 25th ....Board Meetinglow impact
Cruxal's analysis: Bacil Pharma Limited has issued a formal intimation regarding a Board of Directors…
Read the full analysis - Outcome of Board Meeting held on 12th August, 2026Board Meetinglow impact
Cruxal's analysis: Bacil Pharma Limited reported nil revenue from operations for the quarter ended 30th June…
Read the full analysis - Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting for ....Board Meetinglow impact
Cruxal's analysis: Bacil Pharma Limited has issued a formal intimation regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Bacil Pharma Ltd
Cruxal reads every Bacil Pharma Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.